Identification and characterization of the methyl arginines in the fragile X mental retardation protein Fmrp.

Fragile X syndrome is the most common form of inherited mental retardation and is caused by the absence of expression of the FMR1 gene. The protein encoded by this gene, Fmrp, is an RNA-binding protein that binds a subset of mRNAs and regulates their translation, leading to normal cognitive function. Although the association with RNAs is well established, it is still unknown how Fmrp finds and assembles with its RNA cargoes and how these activities are regulated. We show here that Fmrp is post-translationally methylated, primarily on its arginine-glycine-glycine box. We identify the four arginines that are methylated and show that cellular Fmrp is monomethylated and asymmetrically dimethylated. We also show that the autosomal paralog Fxr1 and the Drosophila ortholog dFmr1 are methylated post-translationally. Recombinant protein arginine methyl transferase 1 (PRMT1) methylates Fmrp on the same arginines in vitro as in cells. In vitro methylation of Fmrp results in reduced binding to the minimal RNA sequence sc1, which encodes a stem loop G-quartet structure. Our data identify an additional mechanism, arginine methylation, for modifying Fmrp function and suggest that methylation occurs to limit or modulate RNA binding by Fmrp.

[1]  Stephen T Warren,et al.  Fragile X syndrome , 2008, European Journal of Human Genetics.

[2]  R. Reeves,et al.  Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a. , 2005, Biochemical and biophysical research communications.

[3]  Steven Clarke,et al.  PRMT8, a New Membrane-bound Tissue-specific Member of the Protein Arginine Methyltransferase Family* , 2005, Journal of Biological Chemistry.

[4]  Mark T Bedford,et al.  Arginine methylation an emerging regulator of protein function. , 2005, Molecular cell.

[5]  S. Eddy,et al.  Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. , 2005, Genes & development.

[6]  M. Person,et al.  Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3). , 2005, The Biochemical journal.

[7]  W. Greenough,et al.  Transport of Drosophila fragile X mental retardation protein-containing ribonucleoprotein granules by kinesin-1 and cytoplasmic dynein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Pestka,et al.  Spliceosome Sm proteins D1, D3, and B/B' are asymmetrically dimethylated at arginine residues in the nucleus. , 2004, Biochemical and biophysical research communications.

[9]  K. Lukong,et al.  Arginine methylation signals mRNA export , 2004, Nature Structural &Molecular Biology.

[10]  P. Silver,et al.  PRMT3 is a ribosomal protein methyltransferase that affects the cellular levels of ribosomal subunits , 2004, The EMBO journal.

[11]  Randall W King,et al.  Small Molecule Regulators of Protein Arginine Methyltransferases* , 2004, Journal of Biological Chemistry.

[12]  S. Richard,et al.  Characterization of the Drosophila protein arginine methyltransferases DART1 and DART4. , 2004, The Biochemical journal.

[13]  Daniela C. Zarnescu,et al.  Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway , 2004, Nature Neuroscience.

[14]  J. Glover,et al.  Recognition of 5'-YpG-3' sequences by coupled stacking/hydrogen bonding interactions with amino acid residues. , 2004, Journal of molecular biology.

[15]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[16]  S. Ceman,et al.  Phosphorylation influences the translation state of FMRP-associated polyribosomes. , 2003, Human molecular genetics.

[17]  Xing Zhang,et al.  Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. , 2003, Structure.

[18]  I. Weiler,et al.  RNA Cargoes Associating with FMRP Reveal Deficits in Cellular Functioning in Fmr1 Null Mice , 2003, Neuron.

[19]  J. Glover,et al.  Recognition of 5 0-YpG-3 0 Sequences by Coupled Stacking / Hydrogen Bonding Interactions with Amino Acid Residues , 2003 .

[20]  M. Siomi,et al.  Casein Kinase II Phosphorylates the Fragile X Mental Retardation Protein and Modulates Its Biological Properties , 2002, Molecular and Cellular Biology.

[21]  M. Siomi,et al.  A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. , 2002, Genes & development.

[22]  J. Mandel,et al.  Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. , 2002, Current opinion in genetics & development.

[23]  S. Pongor,et al.  Nerve growth factor‐mediated increases in protein methylation occur predominantly at type I arginine methylation sites and involve protein arginine methyltransferase 1 , 2002, Journal of neuroscience research.

[24]  S. Clarke,et al.  The Novel Human Protein Arginine N-Methyltransferase PRMT6 Is a Nuclear Enzyme Displaying Unique Substrate Specificity* , 2002, The Journal of Biological Chemistry.

[25]  R. Denman Methylation of the arginine-glycine-rich region in the fragile X mental retardation protein FMRP differentially affects RNA binding. , 2002, Cellular & molecular biology letters.

[26]  H. Ruley,et al.  Protein arginine methyltransferase I: Substrate specificity and role in hnRNP assembly , 2002, Journal of cellular biochemistry.

[27]  Gerald M. Rubin,et al.  Drosophila Fragile X-Related Gene Regulates the MAP1B Homolog Futsch to Control Synaptic Structure and Function , 2001, Cell.

[28]  J. Darnell,et al.  Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function , 2001, Cell.

[29]  J. Darnell,et al.  Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.

[30]  C. Ehresmann,et al.  The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif , 2001, The EMBO journal.

[31]  Steven Clarke,et al.  PRMT5 (Janus Kinase-binding Protein 1) Catalyzes the Formation of Symmetric Dimethylarginine Residues in Proteins* , 2001, The Journal of Biological Chemistry.

[32]  E Westhof,et al.  Statistical analysis of atomic contacts at RNA–protein interfaces , 2001, Journal of molecular recognition : JMR.

[33]  Pamela A. Silver,et al.  State of the Arg Protein Methylation at Arginine Comes of Age , 2001, Cell.

[34]  A. Ostareck-Lederer,et al.  Evidence that fragile X mental retardation protein is a negative regulator of translation. , 2001, Human molecular genetics.

[35]  S. Jones,et al.  Protein-RNA interactions: a structural analysis. , 2001, Nucleic acids research.

[36]  Lili Wan,et al.  Characterization of dFMR1, a Drosophila melanogaster Homolog of the Fragile X Mental Retardation Protein , 2000, Molecular and Cellular Biology.

[37]  H. Ruley,et al.  Arginine N-Methyltransferase 1 Is Required for Early Postimplantation Mouse Development, but Cells Deficient in the Enzyme Are Viable , 2000, Molecular and Cellular Biology.

[38]  S. Ceman,et al.  Isolation of an FMRP-Associated Messenger Ribonucleoprotein Particle and Identification of Nucleolin and the Fragile X-Related Proteins as Components of the Complex , 1999, Molecular and Cellular Biology.

[39]  C. H. Lin,et al.  Arginine methylation of a glycine and arginine rich peptide derived from sequences of human FMRP and fibrillarin. , 1999, Proceedings of the National Science Council, Republic of China. Part B, Life sciences.

[40]  P. Silver,et al.  Arginine methylation and binding of Hrp1p to the efficiency element for mRNA 3'-end formation. , 1999, RNA.

[41]  S. Clarke,et al.  S-Adenosylmethionine-dependent Methylation in Saccharomyces cerevisiae , 1999, The Journal of Biological Chemistry.

[42]  J. Tang,et al.  PRMT 3, a Type I Protein Arginine N-Methyltransferase That Differs from PRMT1 in Its Oligomerization, Subcellular Localization, Substrate Specificity, and Regulation* , 1998, The Journal of Biological Chemistry.

[43]  C. Gunter,et al.  Purified Recombinant Fmrp Exhibits Selective RNA Binding as an Intrinsic Property of the Fragile X Mental Retardation Protein* , 1998, The Journal of Biological Chemistry.

[44]  J. Aletta,et al.  Protein methylation: a signal event in post-translational modification. , 1998, Trends in biochemical sciences.

[45]  S. Clarke,et al.  RNA and protein interactions modulated by protein arginine methylation. , 1998, Progress in nucleic acid research and molecular biology.

[46]  B. Cullen,et al.  A nuclear role for the Fragile X mental retardation protein. , 1996, The EMBO journal.

[47]  S. Warren,et al.  The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. , 1996, Human molecular genetics.

[48]  R. Nussbaum,et al.  The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. , 1995, The EMBO journal.

[49]  R. Nussbaum,et al.  FXR1, an autosomal homolog of the fragile X mental retardation gene. , 1995, The EMBO journal.

[50]  G. Dreyfuss,et al.  In vivo and in vitro arginine methylation of RNA-binding proteins , 1995, Molecular and cellular biology.

[51]  W. Paik,et al.  Effect of enzymic methylation of heterogeneous ribonucleoprotein particle A1 on its nucleic-acid binding and controlled proteolysis. , 1994, The Biochemical journal.

[52]  R. Nussbaum,et al.  Essential role for KH domains in RNA binding: Impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome , 1994, Cell.

[53]  S. Warren,et al.  FMR1 protein: conserved RNP family domains and selective RNA binding. , 1993, Science.

[54]  S. Clarke,et al.  Early responses of PC‐12 cells to NGF and EGF: Effect of K252a and 5′‐methylthioadenosine on gene expression and membrane protein methylation , 1993, Journal of neuroscience research.

[55]  J. Mandel,et al.  The FMR–1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation , 1993, Nature Genetics.

[56]  R. Nussbaum,et al.  The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein , 1993, Cell.

[57]  D. Aswad,et al.  Accumulation of substrates for protein L-isoaspartyl methyltransferase in adenosine dialdehyde-treated PC12 cells. , 1993, The Journal of biological chemistry.

[58]  G. Dreyfuss,et al.  The pre-mRNA binding K protein contains a novel evolutionarily conserved motif. , 1993, Nucleic acids research.

[59]  J. Sutcliffe,et al.  Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.

[60]  R I Richards,et al.  Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n , 1991, Science.

[61]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[62]  J. Mandel,et al.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome , 1991, Science.

[63]  D. Aswad,et al.  Diversity of methyl acceptor proteins in rat pheochromocytoma (PC12) cells revealed after treatment with adenosine dialdehyde. , 1990, The Journal of biological chemistry.

[64]  R. Tanguay,et al.  Methylation of Drosophila histones at proline, lysine, and arginine residues during heat shock. , 1988, The Journal of biological chemistry.

[65]  B. Mirkin,et al.  Effect of adenosine analogues on protein carboxylmethyltransferase, S-adenosylhomocysteine hydrolase, and ribonucleotide reductase activity in murine neuroblastoma cells. , 1987, Cancer Research.

[66]  L. Greene,et al.  PC12 Pheochromocytoma Cultures in Neurobiological Research , 1982 .